, /PRNewswire/ — AG Mednet, a leader in clinical trial workflow and process automation, is excited to announce the launch of AI-Assisted Redaction within its Judi platform. This powerful new capability leverages advanced artificial intelligence to streamline the process of identifying and redacting Protected Health Information (PHI), Personally Identifiable Information (PII) and other targeted data across complex and extensive information contained within patient medical records, ensuring regulatory compliance while removing the burden of a tedious and manual task that challenges many clinical teams today.
AG Mednet Releases AI-Assisted Redaction Capabilities in Judi Platform, Driving Regulatory Compliance in Clinical Trials
The Judi platform’s AI-Assisted Redaction tool is designed to address one of the most time-consuming aspects of clinical trial data handling: secondary PHI redaction. By using AI to detect PHI throughout entire documents—including but not limited to names, addresses, date of birth, IDs, and contact information as defined by HIPAA and …